Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Niacin and Tubocurarine

supplement:

Niacin

supplement:

Tubocurarine

Research Papers that Mention the Interaction

Furthermore, both signals were blocked by D-tubocurarine , insinuating the nicotinic character of oxo-M in adrenal chromaffin cells from bovine.
Molecular and Cellular Biochemistry  •  2004  |  View Paper
The specific nicotinic antagonists hexamethonium bromide (100 microM), dihydro-beta-erythroidine (50 microM), mecamylamine (50 microM), and tubocurarine (50 microM) blocked the responses to nicotinic agonists.
Journal of neurophysiology  •  1997  |  View Paper
The nicotinic antagonists d-tubocurarine and dihydro-beta-erythroidine (DH beta E, both 10 microM) reversibly reduced the reliability of the spike firing during swimming and reduced the amplitude of the on-cycle EPSP by 16%.
The nicotinic antagonists mecamylamine and d-tubocurarine (both 5 microM) reduced the duration of episodes of fictive swimming recorded from the ventral roots, in spinal embryos.
Journal of neurophysiology  •  1995  |  View Paper
The nicotinic response was antagonized by dihydro‐beta‐erythroidine, d‐tubocurarine and mecamylamine (10‐20 microM) but not by alpha‐bungarotoxin (10 microM).
The Journal of physiology  •  1994  |  View Paper
Additions of the nicotinic antagonists hexamethonium and D-tubocurarine to the bathing solution reversibly attenuated the ACh-induced depolarization, while the muscarinic antagonist atropine did not have any effect.
Brain Research  •  1989  |  View Paper
Nicotinic cholinergic blocker, d-tubocurarine , inhibited to a greater extent responses to nicotinic cholinomimetics, while atropine, muscarinic cholinergic blocker, inhibited responses to muscarinic cholinomimetics.
Neirofiziologiia = Neurophysiology  •  1988  |  View Paper
This effect of MCC to increase ACh release from rat hippocampus and frontal cortex was antagonized by the nicotinic antagonists dihydro‐β‐erythroidine and d‐tubocurarine , but not by α‐bungarotoxin or by the muscarinic antagonist atropine.
Journal of neurochemistry  •  1988  |  View Paper
The presence of nicotinic presynaptic receptors blocked by tubocurarine , and muscarinic presynaptic receptors blocked by atropine, which regulate synaptic transmission by facilitating and depressing the ACh release respectively, is discussed.
The Journal of physiology  •  1987  |  View Paper
This increase of Li+ uptake by Carb was inhibited by d-tubocurarine , an antagonist of nicotinic AChR. Thus, a new method was established for detection of the activity of nicotinic AChR synthesized in oocytes injected with exogenous mRNA.
Analytical biochemistry  •  1986  |  View Paper
Their primary mode of action appears to be as agonists at the level of the acetylcholine receptor, a view supported by the observation that their effects may be blocked by the nicotinic antagonists d-tubocurarine and gallamine.
European journal of pharmacology  •  1985  |  View Paper
Show More